Patient info Open main menu

Sonata - patient leaflet, side effects, dosage

Contains active substance:

ATC code:

Dostupné balení:

Patient leaflet - Sonata

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

Keep this leaflet. You may need to read it again.

If you have any further questions, ask your doctor or pharmacist.

This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

What is in this leaflet

  • 1.

  • 2.

  • 3.

  • 4.

  • 5.

  • 6.


1.


What Sonata is and what it is used for

What you need to know before you take Sonata

How to take Sonata

Possible side effects

How to store Sonata

Contents of the pack and other information

What Sonata is and what it is used for

Sonata belongs to a class of substances called benzodiazepine-related medicinal products, which consists of preparations with hypnotic actions.

Sonata will help you to sleep. Sleeping problems do not usually last long, and most people only need a short course of treatment. The duration of treatment should usually vary from a few days to two weeks. If you still have problems sleeping after you have finished your capsules, contact your doctor again.

2. What you need to kno


Do not take Sonata


re you take Sonata



if you are a section 6). if you have



o zaleplon or any of the other ingredients of this medicine (listed in


leep apnoea syndrome (stopping breathing for short periods while asleep).


if you have severe kidney or liver problems.

if you have myasthenia gravis (very weak or tired muscles).

if you have severe breathing or chest problems.


If you are in any doubt about whether you have any of these conditions, do ask your doctor. Children and adolescents under 18 years of age must not take Sonata.

Warnings and precautions

Talk to your doctor or pharmacist before taking Sonata.

  • Never drink alcohol while you are being treated with Sonata. Alcohol can increase the undesirable effects of any medicine taken to help you sleep.
  • Use with extreme caution if you have ever been addicted to medicines or alcohol.
  • If you are taking any medicines belonging to the sleep inducing group, including Sonata, there is a possibility that you may become dependent on them. Once physical dependence has developed, abrupt termination of treatment may be accompanied by withdrawal symptoms.

These may consist of headaches, muscle pain, extreme anxiety, tension, restlessness, confusion and irritability.

  • Do not use Sonata or any other sleeping medicine for longer than your doctor tells you to.
  • Do not use a second dose of Sonata within a single night.
  • If your sleeplessness persists or worsens after a short course of Sonata treatment contact your doctor.
  • There is a chance that you may experience a certain type of temporary memory loss (amnesia) and lack of coordination when taking sleep medicines. This can usually be avoided if you remain inactive for at least 4 hours after taking Sonata.
  • There is a chance that you may experience somnambulism (sleepwalking), including eating or driving while not fully awake with no memory of the event. If you experience these events, contact your doctor immediately.
  • Reactions like restlessness, agitation, irritability, aggressiveness, abnormal thinking, delusion, rages, nightmares, depersonalisation, hallucinations, psychoses, inappropriate behaviour, extroversion that seems out of character and other behavioural effects have been reported following use of any medicines belonging to the sleep inducing group, including Sonata. These reactions may be active substance-induced, spontaneous in origin, or a result of an underlying psychiatric or physical disorder. They are more likely to occur in the elderly. If you experience these events, contact your doctor immediately.
  • Rare cases of severe allergic reactions have been reported. An allergic reaction may include a rash, itching, difficulty breathing or swelling of the face, lips, throat or tongue, or nausea and vomiting. If you experience any of these events, contact your doctor immediately.

Children and adolescents

Do not give this medicine to children and adolescents under 18 years of age.

Other medicines and Sonata

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Do not take any other medicines without asking your doctor or pharmacist first. This includes medicines that can be bought without a prescription. Some can cause drowsiness and should not be taken while taking Sonata.

When Sonata is taken with other medicines that act on the brain, the combination may make you more drowsy than it should. Be aware that such combinations may cause you to feel drowsy the next day. These medicines include: substances used in the treatment of mental conditions (antipsychotics, hypnotics, anxiolytics/se­datives, antidepressants), medicines used for strong pain relief (narcotic analgesics), medicines used for the treatment of seizures/convul­sions (antiepileptic medicines), medicines used for loss of feeling/ insensibility (anaesthetics), and medicines used in the treatment of allergies (sedative antihistamines). Drinking alcohol while being treated with Sonata may also cause you to feel drowsy the next day. Never drink alcohol while you are being treated with Sonata (see “Warnings and precautions”).

You should tell your doctor or pharmacist if you are taking cimetidine (a stomach medicine) or erythromycin (an antibiotic).

Sonata with food, drink and alcohol

It is not recommended that you take Sonata with or immediately after eating a large meal as it may work more slowly. Swallow the capsule(s) with a small glass of water. Never drink alcohol while you are being treated with Sonata (see “Warnings and precautions”).

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Sonata should not be taken at these times because there are not enough clinical data available to assess its safety during pregnancy and breast-feeding.

Driving and using machines

Sonata may make you feel drowsy, cause loss of concentration or memory or muscle weakness. This feeling may be even worse when you sleep for less than 7 to 8 hours after taking your medication or if you are already taking another central nervous system depressant or if you are drinking alcohol (see ‘other medicines and Sonata’). If affected do not drive or operate machinery.

Sonata contains lactose.

our doctor


If you have been told by your doctor that you have an intolerance to some sugars, c before taking this medicinal product.

3. How to take Sonata

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

The usual dose for adults is 10 mg just before going to bed, or after you have gone to bed and you are having difficulty falling asleep. You should not take a second dose within a single night.

There are different doses for people who are 65 problems:

65 or older: Take one 5 mg capsule

Mild to moderate liver problems: Take o



, and those who have mild to moderate liver


Sonata has been designed, so that if the contents of the capsule are dissolved in liquid, the liquid will change colour and become cloudy.

If you take more Sonata than you should

Contact a doctor unaccompanied


iately and say how many capsules you have taken. Do not go medical help.

If an ov probabl


s been taken you may become increasingly drowsy very quickly, with high doses to a coma.

If you forget to take Sonata

Just take your next capsule at the usual time, then go on as before. Do not try and catch up on the doses you have missed.

If you stop taking Sonata

On stopping treatment, your original sleeplessness may return and you may experience symptoms such as mood changes, anxiety, and restlessness. If you suffer from these symptoms, ask your doctor for advice.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them. If you notice any of the following, or any other changes in your health, do tell your doctor as soon as possible.

The frequency of possible side effects listed below is defined using the following convention: very common (affects more than 1 user in 10) common (affects 1 to 10 users in 100) uncommon (affects 1 to 10 users in 1,000) rare (affects 1 to 10 users in 10,000) very rare (affects less than 1 user in 10,000) not known (frequency cannot be estimated from the available data)

Side effects that may occur commonly: drowsiness; memory difficulties; sensations like tingling, e.g. in the extremities (paraesthesia); painful menstruation.

Uncommon side effects include: dizziness; weakness; reduced coordination of movements; unsteadiness and/or falls (ataxia); decreased concentration; apathy; restlessness; depression; agitation; irritability; confusion; abnormal thinking and behaviour (extroversion that seems out of character, decreased inhibition, aggressiveness, rages, delusion, depersonalisation, psychosis); nightmares; hallucinations; double vision or other sight problems; increased sensitivity to noise (hyperacusis); smell disorder (parosmia); speech disorders, including slurred speech; numbness, e.g. in the extremities (hypoaesthesia); nausea; decreased appetite; increased sensitivity to light (sunlight, UV light); feeling vaguely ill (malaise).

In very rare cases, allergic reactions, some severe, sometimes with difficulty in breathing, have been reported and may require immediate medical care. An allergic reaction may also include a rash, itching, or swelling of the face, lips, throat or tongue.

Increases in transaminases (a group of liver enzymes occurring naturally in the blood) have been reported, which may be a sign of liver problems.

If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this- leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Sonata

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.

This medicinal product does not require any special temperature storage conditions.

If you have any further questions, please consult your doctor or pharmacist.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other informationThe active substance in each Sonata hard capsule is zaleplon 5 mg.

The other ingredients are microcrystalline cellulose, pregelatinised starch, silicon dioxide, sodium lauryl sulphate, magnesium stearate, lactose monohydrate, indigo carmine (E132), titanium dioxide (E171).


Ingredients of the capsule shell: gelatin, titanium dioxide (E171), red iron oxide (E172), oxide (E172), black iron oxide (E172) and sodium lauryl sulphate. Printing inks on th the following (gold ink SB-3002): shellac, ammonium hydroxide, yellow iron oxid

iron contain


What Sonata looks like and contents of the pack

Sonata 5 mg hard capsules, which contain a light blue powder, have a light brown cap and white body, with gold imprint “5 mg”. They are packed in blisters. Each pack contains 7, 10 or 14 hard capsules. Not all pack sizes may be marketed.

Marketing Authorisation Holder and Manufacturer


Marketing Authorisation holder:

Meda AB

Pipers vag 2A

S-170 73 Solna

Sweden



turer:

MEDA Manufacturing GmbH

Neurather Ring 1 51063 Cologne

Germany


For any information about thi Authorisation Holder.


cine, please contact the local representative of the Marketing


België/Belgique/B MEDA Pharma S. Chaussée de la Terhulpsest B-1170 B



Tél/Tel:

5 04 08 11

166


Lietuva

Meda Pharma SIA

Veiveri4 134

LT – 46352 Kaunas

Tel.: +370 37 330 509


Etnrapua

Tn Mega OapMacoňmuKanc

Yn. OgpuH 71–75, em.2, an 7 1303 Co$ua

Ten.: +359 2 4177977


Luxembourg/Lu­xemburg MEDA Pharma S.A./N.V. Chaussée de la Hulpe 166/ Terhulpsesteenweg 166 B-1170 Brussels Belgique/Belgien

Tél/Tel: +32 2 5 04 08 11


Česká republika MEDA Pharma s.r.o.

Kodaňská 1441/46 CZ 100 10 Praha 10

Tel: +420 234 064 203


Magyarország

MEDA PHARMA Hungary Kereskedelmi Kft.

H-1139 Budapest

Váci ut 91

Tel.: +36 1 236 3410

Deutschland

MEDA Pharma GmbH & Co. KG

Benzstraße 1

D-61352 Bad Homburg v.d.H.

Tel: + 49 6172 888 01


Nederland

MEDA Pharma B.V.

Krijgsman 20

NL-1186 DM Amstelveen

Tel: +31 20 751 65 00


Eesti

Meda Pharma SIA

Narva mnt 11D

EE – 10151 Tallinn, Eesti

Tel. + 372 6261 025


Norge

Meda A/S Askerveien 61 N-1384 Asker

Tlf: +47 66 75 33 00



EUáSa

MEDA Pharmaceuticals AE

EupuTaviaç 3

GR-15231 XaXávSpi-ATTiK^

Tql: +30 210 6 77 5690


Österrei

M G


España

MEDA Pharma S.A.U.

Avenida de Castilla, 2

Parque Empresarial San Fernando

Edificio Berlin


Polska

Meda Pharmaceuticals Sp. z o.o.

Al. Jana Pawla II nr 15 PL-00–828 Warszawa Tel: +48 22 697 7100


a GmbH


e 15

Wien : + 43 1 86 390 0


E-28830 San Fernando de Henares (Madrid)

Tel: +34 91 669 93 00


France

MEDA PHAR

25 Bd. de l'Ai


ruix


F-75016 Paris

Tél : +33 156 64 10 70


Portugal

MEDA Pharma Produtos Farmacéuticos SA

Rua do Centro Cultural 13

P-1749–066 Lisboa

Tel: +351 21 842 0300


Hrvatska


România


Medical Intertrade d.o.o. Dr. Franje Tudmana 3 10431 Sveta Nedelja Tel: +385 1 3374 010


MEDA Pharmaceuticals Switzerland GmbH

Reprezentanta Romania

Calea Floreasca 141–143, et.4

014467 Bucuresti

Tel.: +40 21 230 90 30


Danmark

Meda A/S

Solvang 8

DK-3450 Allerod

Tlf: +45 44 52 88 88

Malta

Alfred Gera & Sons Ltd.

10, Triq il-Masgar Qormi QRM 3217 Tel: +356 2092 4000

Ireland

Meda Health Sales Ireland Limited,

Unit 34/35, Block A,

Dunboyne Business Park, Dunboyne

Co. Meath

Tel: +353 1 802 66 24

island

Meda AB

Box 906

S-170 09 Solna

Svi^jôô.

Simi: +46 8 630 1900


Slovenija

MEDA Pharmaceuticals Switzerland GmbH,

Podruznica Ljubljana

Cesta 24. junija 23

Ljubljana

Tel: +386 59 096 951


Slovenská republika MEDA Pharma spol. s r.o..

Trnavská cesta 50

SK-821 02 Bratislava

Tel: +421 2 4914 0171


Italia

Meda Pharma S.p.A.

Viale Brenta, 18

I-20139 Milano

Tel: +39 02 57 416 1


Suomi/Finland

Meda Oy

Vaisalantie 4/ Vaisalavägen

FI-02130 Espoo/ Esbo

Puh/Tel: +358 20 720 9


Kunpoç

MEDA Pharmaceuticals AE

EupuTaviaç 3

GR-15231 XaXávSpi-ATTiK^

EUáSa

Tql: +30 210 6 77 5690


Sverige

Meda AB

Box 906

S-170 09 Solna



Tel: +4


1900


Latvija

Meda Pharma SIA

Vienîbas gatve 109

LV-1058 Riga, Latvia Tel.: +371 67616137


This leaflet was la


United Kingdom

Meda Pharmaceuticals Ltd.

Skyway House

Parsonage Road

Takeley

Bishop's Stortford

CM22 6PU – UK

Tel: +44 845 460 0000

Detailed information on this medicine is available on the European Medicines Agency web site:.

Similar medicines